VERO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VERO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Venus Concept's Revenue for the three months ended in Mar. 2024 was $17.48 Mil. Venus Concept's average Accounts Receivable for the three months ended in Mar. 2024 was $28.16 Mil. Hence, Venus Concept's Receivables Turnover for the three months ended in Mar. 2024 was 0.62.
The historical data trend for Venus Concept's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Venus Concept Annual Data | |||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
Receivables Turnover | Get a 7-Day Free Trial | 3.37 | 1.40 | 2.12 | 2.36 | 2.30 |
Venus Concept Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Receivables Turnover | Get a 7-Day Free Trial | 0.54 | 0.52 | 0.49 | 0.57 | 0.62 |
For the Medical Devices subindustry, Venus Concept's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Venus Concept's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Venus Concept's Receivables Turnover falls into.
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
Venus Concept's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as
Receivables Turnover (A: Dec. 2023 ) | |||||||
= | Revenue | / | Average Total Inventories | ||||
= | Revenue (A: Dec. 2023 ) | / ( | (Accounts Receivable (A: Dec. 2022 ) | + | Accounts Receivable (A: Dec. 2023 )) | / | count ) |
= | 76.354 | / ( | (37.262 | + | 29.151) | / | 2 ) |
= | 76.354 | / | 33.2065 | ||||
= | 2.30 |
Venus Concept's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as
Receivables Turnover (Q: Mar. 2024 ) | |||||||
= | Revenue | / | Average Total Inventories | ||||
= | Revenue (Q: Mar. 2024 ) | / ( | (Accounts Receivable (Q: Dec. 2023 ) | + | Accounts Receivable (Q: Mar. 2024 )) | / | count ) |
= | 17.479 | / ( | (29.151 | + | 27.168) | / | 2 ) |
= | 17.479 | / | 28.1595 | ||||
= | 0.62 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Venus Concept (NAS:VERO) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Thank you for viewing the detailed overview of Venus Concept's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Anthony Natale | director | 235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8 |
Ross Portaro | officer: President Global Sales | 235 YORKLAND BLVD, SUITE 900, TORONTO Z4 M2J 4Y8 |
Michael Willingham Masters | 10 percent owner | 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305 |
Silva Rajiv De | director, officer: Chief Executive Officer | 1400 ATWATER DRIVE, MALVERN PA 19355 |
Stanley Tyler Hollmig | director | 235 YORKLAND BLVD, SUITE 900, TORONTO Z4 M2J 4Y8 |
Hemanth Jacob Varghese | officer: President/Chief Bus. Officer | 330 JOICEY BOULEVARD, TORONTO A6 M5M2W1 |
Marlin Fund, Limited Partnership | 10 percent owner | MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305 |
Masters Capital Management Llc | 10 percent owner | 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305 |
Marlin Fund Iii, Limited Partnership | 10 percent owner | MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305 |
Marlin Master Fund Offshore Ii, Lp | 10 percent owner | WAYSTONE CORP SV (CAYMAN) LTD, STE 5B201, FL 2, 1 NEXUS WAY, CAMANA BAY, BOX 1344, GRAND CAYMAN E9 KY1-1108 |
Mss Vc Spv Lp | 10 percent owner | C/O MASTERS SPECIAL SITUATIONS, LLC, 3060 PEACHTREE ROAD, NW, STE.1425, ATLANTA GA 30305 |
Marlin Fund Ii, Limited Partnership | 10 percent owner | MASTERS CAPITAL MANAGEMENT, LLC, 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305 |
Masters Special Situations, Llc | 10 percent owner | 3060 PEACHTREE ROAD NW, SUITE 1425, ATLANTA GA 30305 |
Penna Domenic Della | officer: Chief Financial Officer | 235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8 |
Anna Georgiadis | officer: VP, Global HR | 235 YORKLAND BLVD., SUITE 900, TORONTO A6 M2J 4Y8 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 12-15-2021
By GuruFocusNews GuruFocusNews • 04-25-2022
By GuruFocusNews GuruFocusNews • 01-10-2022
By Don Li2 Don Li2 • 11-10-2021
By Marketwired • 10-12-2023
By GuruFocusNews GuruFocusNews • 02-08-2022
By Value_Insider Value_Insider • 10-19-2022
By sperokesalga sperokesalga • 03-20-2023
By Marketwired • 10-09-2023
By Marketwired • 09-06-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.